Mendelian Randomization Analyses for Selection of Therapeutic Targets for Cardiovascular Disease Prevention: a Note of Circumspection

Cardiovascular Drugs and Therapy
Robert S Rosenson, Wolfgang Koenig

Abstract

Genetic factors identified from genome-wide association studies have been used to understand causative variants for complex diseases. Studies conducted on large populations of individuals from many geographical regions have provided insights into genetic pathways involved in the causal pathway for atherosclerotic cardiovascular disease. A single genetic trait may ineffectively evaluate the pathway of interest, and it may not account for other complementary genetic pathways that may be activated at various stages of the disease process or evidence-based therapies that alter the molecular and cellular milieu.

References

Sep 1, 1993·Journal of the American College of Cardiology·R S Rosenson
Aug 3, 2000·International Journal of Epidemiology·S Greenland
Jan 10, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·S A JonesG M Fuller
Dec 18, 2001·Cardiovascular Research·Remco NijmeijerHans W M Niessen
Oct 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Nejma AmezianeDominique de Prost
Feb 21, 2004·Science·Scott W AltmannMichael P Graziano
Mar 24, 2006·The New England Journal of Medicine·Jonathan C CohenHelen H Hobbs
Jul 28, 2006·International Journal of Epidemiology·Bernard KeavneyRory Collins
May 5, 2007·Science·Anna HelgadottirKari Stefansson
May 5, 2007·Science·Ruth McPhersonJonathan C Cohen
Jul 20, 2007·The New England Journal of Medicine·Nilesh J SamaniUNKNOWN WTCCC and the Cardiogenics Consortium
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Jun 19, 2008·JAMA : the Journal of the American Medical Association·Alexander ThompsonJohn Danesh
Sep 10, 2008·Nature Biotechnology·Lisa Melton, Amy Coombs
Oct 22, 2008·Cardiovascular Drugs and Therapy·John E Burke, Edward A Dennis
Feb 10, 2009·Nature Genetics·UNKNOWN Myocardial Infarction Genetics ConsortiumDavid Altshuler
Jul 2, 2009·JAMA : the Journal of the American Medical Association·Paul ElliottJaspal S Kooner
Oct 30, 2009·Current Cardiology Reports·Robert S Rosenson, Michael H Gelb
Sep 3, 2010·Expert Opinion on Investigational Drugs·Robert S RosensonColin Hislop
Sep 25, 2010·Journal of the American College of Cardiology·Robert S RosensonDavid Waters
Nov 19, 2010·The New England Journal of Medicine·Christopher P CannonUNKNOWN Determining the Efficacy and Tolerability Investigators
Jun 23, 2011·JAMA : the Journal of the American Medical Association·David PreissKausik K Ray
Oct 13, 2011·Cardiovascular Drugs and Therapy·Robert S RosensonColin Hislop
Jan 6, 2012·Science Translational Medicine·Eric E Schadt, Johan L M Björkegren
Mar 17, 2012·Lancet·UNKNOWN IL6R Genetics Consortium Emerging Risk Factors CollaborationJohn Danesh
Mar 17, 2012·Lancet·UNKNOWN Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) ConsortiumJuan Pablo Casas
Apr 18, 2012·Circulation·Robert S RosensonLaurent Yvan-Charvet
May 3, 2012·Journal of Lipid Research·Philip J Barter, Kerry-Anne Rye
Jun 6, 2012·Journal of Lipid Research·Robert S Rosenson, Diana M Stafforini
Jul 18, 2012·European Heart Journal·Robert S Rosenson, Eva Hurt-Camejo
Nov 7, 2012·The New England Journal of Medicine·Gregory G SchwartzUNKNOWN dal-OUTCOMES Investigators

❮ Previous
Next ❯

Citations

Aug 11, 2017·Nature Reviews. Cardiology·Robert S RosensonRobert A Hegele
Mar 12, 2016·Arteriosclerosis, Thrombosis, and Vascular Biology·Robert S Rosenson
Oct 18, 2018·Current Cardiology Reports·Lane B BenesMichael H Davidson
Jul 30, 2019·International Reviews of Immunology·Yan ChenWei-Min Deng
Jun 15, 2018·Frontiers in Cardiovascular Medicine·Le ShuXia Yang
Dec 19, 2019·Cardiovascular Drugs and Therapy·Willem J Remme
Jan 1, 2016·Current Genetic Medicine Reports·Jacqueline S Dron, Robert A Hegele

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.